Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America Guidelines for Developing an Institutional Program to Enhance Antimicrobial Stewardship
Year: 2006
Type: article
Abstract: This document presents guidelines for developing institutional programs to enhance antimicrobial stewardship, an activity that includes appropriate selection, dosing, route, and duration of antimicrobial therapy.The multifaceted nature of antimicrobial stewardship has led to collaborative review and support of these recommendations by the following organizations: American Academy of Pediatrics, American Society of Health-System Pharmacists, Infectious Diseases Society for Obstetrics and Gynecology, Pediatric Infectious Diseases Society, Society for Hospital Medicine, and Society of Infectious Diseases Pharmacists.The primary goal of antimicrobial stewardship is to optimize clinical outcomes while minimizing unintended consequences of antimicrobial use, including toxicity, the selection of pathogenic organisms (such as Clostridium difficile), and the emergence of resistance.Thus, the appropriate use of antimicrobials is an essential part of patient safety
Source: Clinical Infectious Diseases
DOI: 10.1086/510393
Institutions: University of Washington, Harborview Medical Center, Maine Medical Center, Emory University, Edward Hines, Jr. VA Hospital, Rush University Medical Center, John H. Stroger, Jr. Hospital of Cook County, University of Utah, Mayo Clinic, University of Pittsburgh Medical Center, University of Pennsylvania, Corewell Health William Beaumont University Hospital, Ochsner Health System, University of Miami
Language: English
Subfield: Applied Microbiology and Biotechnology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: bronze
Funders: Pfizer, AstraZeneca, Viropharma, Gojo Industries
OpenAlex ID: W2168908910